149 related articles for article (PubMed ID: 34554592)
21. Pyoderma gangrenosum and concomitant hidradenitis suppurativa--rapid response to canakinumab (anti-IL-1β).
Jaeger T; Andres C; Grosber M; Zirbs M; Hein R; Ring J; Traidl-Hoffmann C
Eur J Dermatol; 2013; 23(3):408-10. PubMed ID: 23816498
[No Abstract] [Full Text] [Related]
22. PASH syndrome with bony destruction.
McCarthy S; Foley CC; Dvorakova V; Quinlan C; Murphy M; Maher M
Clin Exp Dermatol; 2019 Dec; 44(8):918-920. PubMed ID: 30666706
[No Abstract] [Full Text] [Related]
23. Pyoderma gangrenosum associated with hidradenitis suppurativa.
Ah-Weng A; Langtry JA; Velangi S; Evans CD; Douglas WS
Clin Exp Dermatol; 2005 Nov; 30(6):669-71. PubMed ID: 16197385
[TBL] [Abstract][Full Text] [Related]
24. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy.
Bruzzese V
J Clin Rheumatol; 2012 Dec; 18(8):413-5. PubMed ID: 23188209
[TBL] [Abstract][Full Text] [Related]
25. Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab.
De Wet J; Jordaan HF; Kannenberg SM; Tod B; Glanzmann B; Visser WI
Dermatol Online J; 2017 Dec; 23(12):. PubMed ID: 29447652
[TBL] [Abstract][Full Text] [Related]
26. Pyoderma gangrenosum, acne, hidradenitis suppurativa syndrome associated with type 1 diabetes mellitus treated with adalimumab.
Fattore D; Pistone G; Bongiorno MR
G Ital Dermatol Venereol; 2019 Apr; 154(2):218-220. PubMed ID: 29368847
[No Abstract] [Full Text] [Related]
27. Severe ulcerative proctitis, pyoderma gangrenosum, hidradenitis suppurativa and fever in a patient with a rare variant of the PSTPIP1 gene.
Hieta N; Nuutinen H; Roivas J; Salminen K; Kujari H; Talve L; Toivonen M; Haanpää MK
Clin Exp Dermatol; 2021 Oct; 46(7):1387-1390. PubMed ID: 34273117
[No Abstract] [Full Text] [Related]
28. Angiotensin-converting enzyme 2 expression is elevated in tissue of hidradenitis suppurativa and pyoderma gangrenousm and demonstrates a different pattern of expression to psoriasis vulgaris.
Flora A; Frew JW
J Eur Acad Dermatol Venereol; 2023 Mar; 37(3):e372-e374. PubMed ID: 35986694
[No Abstract] [Full Text] [Related]
29. Pyoderma gangrenosum in the head and neck.
Wittekindt C; Lüers JC; Klussmann JP; Hüttenbrink KB
Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):83-5. PubMed ID: 17224531
[No Abstract] [Full Text] [Related]
30. Tildrakizumab in the treatment of PASH syndrome: A potential novel therapeutic target.
Kok Y; Nicolopoulos J; Varigos G; Howard A; Dolianitis C
Australas J Dermatol; 2020 Aug; 61(3):e373-e374. PubMed ID: 32285437
[No Abstract] [Full Text] [Related]
31. Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery.
Marzano AV; Ishak RS; Colombo A; Caroli F; Crosti C
Dermatology; 2012; 225(3):215-9. PubMed ID: 23171584
[TBL] [Abstract][Full Text] [Related]
32. PASH syndrome (pyoderma gangrenosum, acne and hidradenitis suppurativa): a disease with genetic heterogeneity.
Sonbol H; Duchatelet S; Miskinyte S; Bonsang B; Hovnanian A; Misery L
Br J Dermatol; 2018 Jan; 178(1):e17-e18. PubMed ID: 28626985
[No Abstract] [Full Text] [Related]
33. Successful use of adalimumab to treat pyoderma gangrenosum, acne and suppurative hidradenitis (PASH syndrome) following colectomy in ulcerative colitis.
Murphy B; Morrison G; Podmore P
Int J Colorectal Dis; 2015 Aug; 30(8):1139-40. PubMed ID: 25564349
[No Abstract] [Full Text] [Related]
34. PASH syndrome associated with osteopoikilosis.
Gracia-Cazaña T; Frias M; Roselló R; Vera-Álvarez J; Gilaberte Y
Int J Dermatol; 2015 Sep; 54(9):e369-71. PubMed ID: 26175185
[No Abstract] [Full Text] [Related]
35. Remission of refractory pyoderma gangrenosum, severe acne, and hidradenitis suppurativa (PASH) syndrome using targeted antibiotic therapy in 4 patients.
Join-Lambert O; Duchatelet S; Delage M; Miskinyte S; Coignard H; Lemarchand N; Alemy-Carreau M; Lortholary O; Nassif X; Hovnanian A; Nassif A
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S66-9. PubMed ID: 26470620
[TBL] [Abstract][Full Text] [Related]
36. [Anakinra therapy in a patient with multifocal pyoderma gangrenosum and hidradenitis suppurativa].
Oymanns M; Kreuter A; Assaf C
Hautarzt; 2021 May; 72(5):435-438. PubMed ID: 33095334
[TBL] [Abstract][Full Text] [Related]
37. Guess what! Malignant pyoderma responding to cyclosporine.
Cardinali C; Giomi B; Caproni M; Fabbri P
Eur J Dermatol; 2001; 11(6):595-6. PubMed ID: 11701420
[No Abstract] [Full Text] [Related]
38. Traumatic pyoderma gangrenosum of the face: pathergy development after bike accident.
Lindberg-Larsen R; Fogh K
Dermatology; 2009; 218(3):272-4. PubMed ID: 19060470
[TBL] [Abstract][Full Text] [Related]
39. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases.
Moschella SL
Int J Dermatol; 2007 Dec; 46(12):1287-91. PubMed ID: 18173525
[TBL] [Abstract][Full Text] [Related]
40. Adalimumab-induced pyoderma gangrenosum in a patient with hidradenitis suppurativa: A paradoxical reaction.
Company-Quiroga J; Alique-García S; Martínez-Morán C; Khedaoui R; Romero-Maté A; Borbujo J
Indian J Dermatol Venereol Leprol; 2019; 85(4):422-425. PubMed ID: 31115357
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
